Cargando…
Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D
The expression of the Adenovirus serotype 2 or serotype 5 (Ad2/5) E1A gene in tumor cells upregulates ligands that are recognized by the NKG2D activating receptor, which is expressed on NK cells and T cells, and reduces their tumorigenicity, a process dependent on NK cells and T cells. In some model...
Autores principales: | Korrer, Michael J., Routes, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309920/ https://www.ncbi.nlm.nih.gov/pubmed/25685658 http://dx.doi.org/10.1016/j.rinim.2015.01.001 |
Ejemplares similares
-
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection
por: Routes, John M., et al.
Publicado: (2005) -
Possible Role of Arginase-1 in Concomitant Tumor Immunity
por: Korrer, Michael J., et al.
Publicado: (2014) -
NKG2D defines tumor‐reacting effector CD8(+) T cells within tumor microenvironment
por: Mojic, Marija, et al.
Publicado: (2021) -
CD8(+) T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
por: Lerner, Emily C., et al.
Publicado: (2023) -
Correction: Possible Role of Arginase-1 in Concomitant Tumor Immunity
por: Korrer, Michael J., et al.
Publicado: (2016)